Cargando…
Empowering drug development: Leveraging insights from imaging technologies to enable the advancement of digital health technologies
The US Food and Drug Administration (FDA) has publicly recognized the importance of improving drug development efficiency, deeming translational biomarkers a top priority. The use of imaging biomarkers has been associated with increased rates of drug approvals. An appropriate level of validation pro...
Autores principales: | Izmailova, Elena S., Maguire, R. Paul, McCarthy, Timothy J., Müller, Martijn L. T. M., Murphy, Philip, Stephenson, Diane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014695/ https://www.ncbi.nlm.nih.gov/pubmed/36382716 http://dx.doi.org/10.1111/cts.13461 |
Ejemplares similares
-
Digital health technology derived measures: Biomarkers or clinical outcome assessments?
por: Izmailova, Elena S., et al.
Publicado: (2023) -
Digital technologies: Innovations that transform the face of drug development
por: Izmailova, Elena S., et al.
Publicado: (2023) -
Is digital health technology empowering patients?
por: Robinson, Leslie
Publicado: (2013) -
Creating boundaries to empower digital health technology
por: Hsin, Honor, et al.
Publicado: (2018) -
Fit‐for‐Purpose Biometric Monitoring Technologies: Leveraging the Laboratory Biomarker Experience
por: Godfrey, Alan, et al.
Publicado: (2020)